Economy
Bombay High Court Overturns FDA Order Against Cipla
Bar and Bench1h
THE BRIEF
1
The Bombay High Court overturned a Maharashtra FDA order that had cancelled Cipla’s wholesale drug licences for its Wadki, Pune distribution hub, citing high-handed and procedurally unfair conduct.
2
The FDA had issued a cancellation order on August 26, a public holiday, after Cipla requested an adjournment regarding alleged packaging irregularities involving the drug 'Reactin Plus'.
3
Following the court's reprimand, the state government agreed to withdraw the cancellation immediately and must serve a fresh notice to the company before September 4, 2026.